Predictive data to preserve health
Delivering and exploiting data for cardiac decompensation prevention
Our Mission
Providing actionable data to maintain cardiac condition stability
Keep patients at home
Delay the loss of autonomy
Reduce avoidable hospital admissions
At CardiaMetrics, we want to provide telemedicine platforms and physicians with early data to prevent cardiac decompensations and adjust medications to maintain the stability of the cardiac function.
This solution addresses chronic heart failure patients and those undergoing cardiotoxic drugs for cancer treatment.
Heart failure burden
64M
patients globally
20%
of ages 70–85
1.27M
hospitalizations (2018)
$31B
2.25× by 2030
Our Solution
A best-of-breed medical monitoring system utilizing subcutaneous sensors that collect daily vital physiological data able to provide the best digital biomarker today for HF monitoring: intracardiac pressures.
This IoT-enabled solution provides combined and aggregated hemodynamic and electrophysiological data to remote monitoring platforms, enabling healthcare professionals to perform proactive and personalized patient monitoring.
Additionally, our solution helps identify and prioritize patients requiring immediate intervention or therapeutic adjustment, increasing team productivity and focusing their efforts where they are most needed.
Benefits for All Actors
Early data. Targeted actions. Streamlined journey.
Patient
Shorter initial hospitalization
Earlier optimization of at-home treatment.
Fewer exacerbations, fewer readmissions
Early, data-driven adjustments.
Reduced mental burden
Automated monitoring and structured reminders.
Patients empowered in their own care
Integrated therapeutic education.
Healthcare
Improved clinical effectiveness
Early, actionable data.
Enhanced productivity
Reliable data, available every day.
Risk-based patient prioritization
Better resource allocation, less wasted time.
Simplified deployment
Clear pathway, phased integration.
They Trust Us
Coming Soon
We are about to launch our first human trial in partnership with the Caen hospital (Normandy, France).